The eight-year long-term follow-up on the effectiveness of the quadrivalent human papillomavirus vaccine in Chinese women 20-45 years of age

• Autori principali: Chao Zhao (Autore), Yun Zhao (Autore), Jingran Li (Autore), Mingzhu Li (Autore), Yanyan Su (Autore), Xin Mi (Autore), Su Yi La Tu (Autore), Danhua Shen (Autore), Lihua Ren (Autore), Yanyan Li (Autore), Linhong Wang (Autore), Lihui Wei (Autore)
• Natura: Libro
• Pubblicazione: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

The quadrivalent human papillomavirus (4vHPV) vaccine has shown confirmative effectiveness in preventing HPV-related diseases among women and men around the globe. The phase III, randomized, double-blind efficacy study (Base study, NCT00834106) conducted in China showed 100% efficacy against HPV 16/...